Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-06-09

Clinical Trial Update: Use of TpCO2 (Transcutaneous CO2 Measurement) as PaCO2 Predictor During NIV in Case of Acute Hypercapnic Respiratory Failure

View source ↗

Summary

This trial evaluated transcutaneous CO2 (TpCO2) as a predictor of arterial PaCO2 during noninvasive ventilation in acute hypercapnic respiratory failure and has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Lausanne Hospitals | Conditions: Hypercapnic Respiratory Failure | Status: COMPLETED